← Back to Search

Nonopioid Analgesia

Post-Operative Non Opioid Pain Protocol for Drug Abuse

Phase 2 & 3
Recruiting
Led By Toufic R Jildeh, MD
Research Sponsored by Henry Ford Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All adult patients over age 18 and scheduled for a primary or revision labral surgery
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 days post-operatively
Awards & highlights

Study Summary

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 days post-operatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 days post-operatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Levels
Patient-Reported Outcomes Measurement Information System

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Post-Operative Non Opioid Pain ProtocolExperimental Treatment5 Interventions
Patients will be administered a post-operative non-opioid pain protocol consisting of: Celecoxib Ketorolac Gabapentin Acetaminophen Diazepam
Group II: Post-Operative Traditional Pain ProtocolActive Control1 Intervention
Patients will be administered a traditional post-operative pain protocol consisting of: Hydrocodone-acetaminophen 5-325
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Celecoxib
FDA approved
Gabapentin
FDA approved
Acetaminophen
FDA approved
Diazepam
FDA approved
Ketorolac
FDA approved

Find a Location

Who is running the clinical trial?

Henry Ford Health SystemLead Sponsor
299 Previous Clinical Trials
2,098,647 Total Patients Enrolled
Toufic R Jildeh, MDPrincipal InvestigatorHenry Ford Health System
3 Previous Clinical Trials
223 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~16 spots leftby Mar 2025